Shock wave therapy for the treatment of Adhesive Capsulitis

  • Research type

    Research Study

  • Full title

    The effects of extracorporeal shock wave therapy as a treatment intervention for chronic adhesive capsulitis: a mixed methods pilot study.

  • IRAS ID

    337387

  • Contact name

    Crystal Reno

  • Contact email

    c.a.reno@stir.ac.uk

  • Sponsor organisation

    University of Stirling

  • Clinicaltrials.gov Identifier

    NCT06490172

  • Duration of Study in the UK

    1 years, 4 months, 31 days

  • Research summary

    Adhesive capsulitis (AC), also known as frozen shoulder, is a debilitating condition that causes pain and difficulty of moving the shoulder joint. Physiotherapy treatment is often first line treatment management. Patients with failed conservative management are commonly referred to a specialist consultant for further treatment. Over the last 20 years, extracorporeal shock wave therapy (ESWT) has gained popularity as a non-surgical treatment to treat persistent muscle and tendon conditions as it is non-invasive and result in good outcomes with minimal side effects.

    There is limited information for the use of ESWT to treat frozen shoulder. The current research has mixed treatment procedures, nonetheless, report positive outcomes. Due to the varied treatment practice, this study proposes to explore and identify appropriate anatomical treatment locations around the shoulder in addition to the ESWT manufacture guidelines with the opinion of upper limb clinical experts within the UK, and to test the practicality of using ESWT to treat frozen shoulder in the NHS healthcare setting.

    The study will first run a survey, called a Delphi study, to explore expert opinion from upper limb healthcare specialists in the UK to establish an anatomical treatment location to be used in the ESWT Swiss Dolorclast Manufacturers Guideline treatment protocol to treat frozen shoulder. The study will then apply the findings from the Delphi Study using the agreed anatomical treatment locations in a trial, and record follow-up information that measures shoulder joint movement, pain, disability, function, and health-related quality of life. The information recorded will be examined, and the data collected will be used to create interview questions. Participants will be invited at the start of the study to take part in an interview following ESWT treatment. This is to help the researchers learn about public perception of ESWT.

  • REC name

    South East Scotland REC 02

  • REC reference

    24/SS/0071

  • Date of REC Opinion

    10 Oct 2024

  • REC opinion

    Further Information Favourable Opinion